Instituto Nacional de Cancerologia

What Instituto Nacional de Cancerologia does

Instituto Nacional de Cancerología (INC) is Colombia's national cancer reference center, operating as a public healthcare institution (ESE - Empresa Social del Estado) under the Ministry of Health and Social Protection. Founded in 1934 and headquartered in Bogotá, INC provides comprehensive cancer care across the full continuum: prevention, early detection, diagnosis (pathology, imaging, nuclear medicine), treatment (surgery including robotic and micro-surgery, chemotherapy, radiotherapy), rehabilitation, and palliative care. Services are delivered through eight specialized functional units covering head and neck, dermatologic, gynecologic, neuro-, pediatric, thoracic, clinical, and endocrinologic oncology.

The institute's research infrastructure includes the Terry Fox National Tumor Bank, the Red Nacional de Investigación en Cáncer, Minciencias-recognized research groups, and the Revista Colombiana de Cancerología. Educational offerings span a virtual campus, continuing education, and formal training programs. Technology platforms include SIAI and SIAPINC information systems, REDCap for clinical research data, and WhatsApp-based patient scheduling.

INC is funded through Colombia's mandatory healthcare system (SGSSS) via EPS reimbursement and government budget allocations. Revenue is not publicly disclosed. The institution coordinates the Plan Decenal para el Control del Cáncer 2026-2035 and holds international partnerships with INC LATAM, OECI, SWOG, OIEA, ALLCan Colombia, and Institut Curie. Accreditations include Icontec, IQNet, and OIEA Anchor Center designation.

Name

Instituto Nacional de Cancerologia

Legal name

Instituto Nacional de Cancerología

Website

https://cancer.gov.co

Company type

Private

Founded year

1934

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

Colombia's national cancer institute, operating since 1934 as a public ESE under the Ministry of Health. Provides comprehensive cancer care — from prevention through palliative services — alongside research and oncology education, serving as the country's statutory reference center for complex cancer cases.

Ownership category

akta.pro rank

Product category

Cancer Hospital Services

NAICS

Specialty (except Psychiatric and Substance Abuse) Hospitals (6223), Offices of Physicians (62111), Medical and Diagnostic Laboratories (62151)

SIC

Services-Health Services (8000), Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Specialty Outpatient Facilities, Nec (8093)

akta.pro primary industry

Hospital-Integrated Cancer Centers (Acute Oncology Programs) (HLAFAAAM)

akta.pro secondary industries

Medical Oncology (HLAKAFAB), Surgical Oncology (HLAKAFAG), Gynecologic Oncology & Women’s Cancer Centers (HLAFAJAK)

Keywords

• Cancer treatment services
• Oncology clinical care
• Cancer research programs
• Radiation oncology services
• Public health oncology

Headquarters

HQ city

Bogotá

HQ country

Colombia

HQ region

Latin America

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Supply Chain, Marketing or Sales

Revenue model

1. Public Healthcare System Reimbursement: INC operates as a public healthcare institution (ESE - Empresa Social del Estado) within Colombia's national healthcare system (SGSSS). Services are reimbursed through EPS (Administradoras de Planes de Beneficios) based on mandated cancer care coverage.

Go-to-market motion1 record

Distribution channels4 records

Marketing channels6 records

Core offering

Instituto Nacional de Cancerología delivers comprehensive cancer care across the full continuum — prevention, early detection, diagnosis, treatment (including chemotherapy, radiation oncology, robotic and high-complexity surgery), rehabilitation, and palliative care — through specialized clinical functional units. It also runs oncology research programs (clinical trials, cancer biology, epidemiology), postgraduate education and continuing training through Campus Virtual INC, and public-health oncology services that coordinate the national cancer control plan for Colombia.

Product overview

Instituto Nacional de Cancerología (INC) is Colombia's national cancer institute offering comprehensive cancer care through an integrated platform of clinical services, research, and education. The institution operates multiple specialized functional units (Cabeza y Cuello, Dermatología Oncológica, Ginecología Oncológica, Neuro-Oncología, Pediatría Oncológica, Cirugía de Tórax, Oncología Clínica, Endocrinología Oncológica) supported by diagnostic services (pathology, laboratory, radiopharmacy, imaging, nuclear medicine), radiation oncology, and high-complexity procedures (robotic surgery, micro-surgery, Mohs surgery). The portfolio includes oncologic support services (palliative care, mental health, rehabilitation), blood banking, and public health programs. Research infrastructure encompasses clinical trials, the National Cancer Research Network, Terry Fox Tumor Bank, and the Colombian Cancer Journal. Educational offerings include continuing education, a virtual campus, and formal training programs. Technology platforms include SIAI and SIAPINC information systems, REDCap for clinical research, and Infocancer for epidemiological data. INC also manages innovation programs including intellectual property protection and Latin American innovation policy hub.

Differentiator

Problem solved

Functional benefit

Brands

• INC LATAM: Alliance of Cancer Institutes of Latin America - a regional network coordinated by INC for collaborative cancer research and control across Latin America
• Red Nacional de Investigación en Cáncer
• Revista Colombiana de Cancerología
• Banco nacional de tumores Terry Fox
• CON-CIENCIA contra el cáncer
• Campus Virtual INC
• Biblioteca José Antonio Jacome
• No Fumar es la Actitud
• Infocancer

Products and services

• Unidades Funcionales de Atención Clínica Specialized clinical care units covering oncology subspecialties including Head and Neck, Dermatologic Oncology, Gynecologic Oncology, Neuro-Oncology, Pediatric Oncology, Thoracic Surgery, Clinical Oncology, and Oncologic Endocrinology.
• Soporte Oncológico Oncologic support services including palliative care, mental health, nutritional and metabolic support, and oncologic rehabilitation for cancer patients.
• Procedimientos de Alta Complejidad High-complexity surgical procedures including micro-surgery, robotic surgery, advanced laparoscopic surgery, navigation surgery, Sugarbaker procedure, limb salvage surgery, and Mohs micrographic surgery.
• Diagnóstico y Estadificación Cancer diagnosis and staging services including oncologic pathology, laboratory, radiopharmacy, diagnostic imaging, and nuclear medicine.
• Oncología Radioterápica Radiation oncology services for cancer treatment delivered with specialized equipment and procedures, supported by INC's designation as an IAEA Anchor Center for ionizing radiation against cancer.
• Banco de Sangre Blood bank services supporting cancer treatment through blood donation management and transfusion services.
• Docencia y Educación Medical education services including continuing education, virtual campus (Campus Virtual INC), student resources, alumni association, and formal education programs in oncology.
• Salud Pública Oncológica Public health programs focused on cancer prevention, early detection, epidemiological surveillance, policy development, and social mobilization, including the coordination of the Plan Decenal para el Control del Cáncer 2026-2035.
• Investigación Clínica Clinical research programs including cancer biology, clinical and epidemiological investigation, ethics committee oversight, clinical trials (powered by REDCap), and international collaborations.
• Guías de Práctica Clínica Evidence-based clinical practice guidelines for cancer diagnosis, treatment, and follow-up covering breast cancer, prostate cancer, thyroid cancer, and soft tissue sarcomas.

Named customers1 record

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration3 records

Partnerships

Eight partnerships are on record, tiered core, minor and major.

• Alianza de Institutos de Cáncer de América Latina (INC LATAM)coreStrategic or Co-development Partner · 1 May 2024Regional alliance of Latin American cancer institutes for collaborative research, knowledge sharing, and joint initiatives for cancer control in the region. INC serves as a coordinating member of this network.
• Dr. Rifat Atun (Harvard University)minorStrategic or Co-development Partner · 8 February 2024Knowledge exchange visit by Dr. Atun, former Director of the Health Systems Innovation Lab at Harvard, to explore collaboration opportunities in health innovation and public health research.
• OECI (Organization of European Cancer Institutes)majorStrategic or Co-development PartnerEuropean cancer institute network providing access to international standards, best practices, and collaborative research opportunities.
• SWOG Cancer Research NetworkmajorStrategic or Co-development PartnerInternational cancer research network that conducts clinical trials and translational research. INC participates in collaborative clinical studies through this partnership.
• OIEA (Organismo Internacional de Energía Atómica)coreStrategic or Co-development PartnerIAEA partnership for strengthening cancer diagnosis and treatment through radiation technology. INC recognized as an Anchor Center for ionizing radiation against cancer and participates in regional projects to enhance cancer care in Latin America.
• ALLCan ColombiamajorStrategic or Co-development PartnerAffiliation with the All.Can cancer patient organization for improving patient outcomes and care quality.
• Instituto Curie (Francia)majorStrategic or Co-development PartnerMemorandum of understanding signed for collaboration in research, training, and knowledge exchange in oncology.
• Red Nacional de Investigación en CáncercoreStrategic or Co-development PartnerNational cancer research network coordinated by INC that brings together research groups across Colombia to collaborate on cancer research priorities.

Scale indicators2 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Instituto Nacional de Cancerología (Mexico, INCan): Mexico's national cancer institute under the Ministry of Health; operates as a public comprehensive cancer center with research, teaching, and high-complexity oncology services — the closest structural analog to INC Colombia in Latin America.
• A.C. Camargo Cancer Center: Brazilian comprehensive cancer center delivering multidisciplinary oncology care, research, and education; directly comparable to INC in scope of subspecialty units, residency programs, and translational research.
• Hospital de Amor (formerly Hospital de Câncer de Barretos): Large Brazilian public-philanthropic cancer hospital providing full-spectrum oncology care, prevention, and research across multiple units — comparable to INC in mission, public-system reimbursement, and scale.
• Instituto Europeo de Oncología (IEO): European comprehensive cancer center focused on multidisciplinary oncology, research, and training; mirrors INC's integrated care-unit model and academic medical center positioning.
• Institut Curie: French cancer research and treatment center combining hospital, research, and teaching missions; already an INC partner and a structural peer as a multidisciplinary public-mission oncology institution.

Broad incumbents

• MD Anderson Cancer Center: Global benchmark comprehensive cancer center; not a direct competitor in Colombia but operates in the same specialty hospital category and represents the upper-bound scale INC is benchmarked against in academic rankings.
• Memorial Sloan Kettering Cancer Center: U.S.-based specialty cancer hospital with research and education; relevant as a comparable institutional model (cancer-only hospital + research institute) even though geography and funding structure differ.
• Sylvester Comprehensive Cancer Center (University of Miami): NCI-designated academic comprehensive cancer center combining care, research, and population health; comparable institutional archetype with strong international/Latin America patient flows.

Emerging players

• Centro de Investigación del Cáncer (IBMCC, Universidad de Salamanca): Spanish university-affiliated cancer research and care center; a peer-type academic oncology institution with research-network participation overlapping INC's OECI/INC LATAM partnerships.

Regional players

• Fundación Santa Fe de Bogotá: Leading Colombian academic hospital offering high-complexity oncology services within Bogotá; competes for talent, EPS contracts, and complex oncology cases in the same domestic market as INC.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/INCancerologia
• Facebookfacebook.com/INCancerologiaESE
• Instagraminstagram.com/incancerologia

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Instituto Nacional de Cancerologia